nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ABCB1—melanoma	0.248	1	CbGaD
Propafenone—CYP1A2—Carmustine—melanoma	0.0977	0.198	CbGbCtD
Propafenone—CYP1A2—Vemurafenib—melanoma	0.0772	0.156	CbGbCtD
Propafenone—CYP3A4—Temozolomide—melanoma	0.0739	0.149	CbGbCtD
Propafenone—CYP2D6—Vemurafenib—melanoma	0.0636	0.129	CbGbCtD
Propafenone—CYP1A2—Dacarbazine—melanoma	0.0592	0.12	CbGbCtD
Propafenone—ABCB1—Dactinomycin—melanoma	0.0449	0.0909	CbGbCtD
Propafenone—CYP3A4—Vemurafenib—melanoma	0.0405	0.0819	CbGbCtD
Propafenone—ABCB1—Docetaxel—melanoma	0.0232	0.0469	CbGbCtD
Propafenone—CYP3A4—Docetaxel—melanoma	0.0139	0.0281	CbGbCtD
Propafenone—Monobenzone—TYR—melanoma	0.00372	0.43	CrCbGaD
Propafenone—Carvedilol—HIF1A—melanoma	0.00112	0.129	CrCbGaD
Propafenone—Quinapril—SLC15A2—melanoma	0.00106	0.122	CrCbGaD
Propafenone—Benazepril—SLC15A2—melanoma	0.000921	0.107	CrCbGaD
Propafenone—Carvedilol—VEGFA—melanoma	0.00045	0.052	CrCbGaD
Propafenone—Cardiac disorder—Temozolomide—melanoma	0.000365	0.00204	CcSEcCtD
Propafenone—Flushing—Temozolomide—melanoma	0.000365	0.00204	CcSEcCtD
Propafenone—Arrhythmia—Carmustine—melanoma	0.000363	0.00203	CcSEcCtD
Propafenone—Leukopenia—Bleomycin—melanoma	0.000363	0.00203	CcSEcCtD
Propafenone—Dizziness—Vemurafenib—melanoma	0.000361	0.00202	CcSEcCtD
Propafenone—Alopecia—Carmustine—melanoma	0.000359	0.00201	CcSEcCtD
Propafenone—Angiopathy—Temozolomide—melanoma	0.000356	0.00199	CcSEcCtD
Propafenone—Mental disorder—Carmustine—melanoma	0.000356	0.00199	CcSEcCtD
Propafenone—Ataxia—Docetaxel—melanoma	0.000355	0.00198	CcSEcCtD
Propafenone—Immune system disorder—Temozolomide—melanoma	0.000355	0.00198	CcSEcCtD
Propafenone—Mediastinal disorder—Temozolomide—melanoma	0.000354	0.00198	CcSEcCtD
Propafenone—Erythema—Carmustine—melanoma	0.000354	0.00198	CcSEcCtD
Propafenone—Malnutrition—Carmustine—melanoma	0.000354	0.00198	CcSEcCtD
Propafenone—Cough—Bleomycin—melanoma	0.000354	0.00198	CcSEcCtD
Propafenone—Dehydration—Docetaxel—melanoma	0.000351	0.00196	CcSEcCtD
Propafenone—Ill-defined disorder—Dactinomycin—melanoma	0.000351	0.00196	CcSEcCtD
Propafenone—Anaemia—Dactinomycin—melanoma	0.00035	0.00195	CcSEcCtD
Propafenone—Liver function test abnormal—Docetaxel—melanoma	0.000349	0.00195	CcSEcCtD
Propafenone—Vomiting—Vemurafenib—melanoma	0.000347	0.00194	CcSEcCtD
Propafenone—Alopecia—Temozolomide—melanoma	0.000347	0.00194	CcSEcCtD
Propafenone—Dry skin—Docetaxel—melanoma	0.000346	0.00193	CcSEcCtD
Propafenone—Chest pain—Bleomycin—melanoma	0.000345	0.00193	CcSEcCtD
Propafenone—Myalgia—Bleomycin—melanoma	0.000345	0.00193	CcSEcCtD
Propafenone—Orthostatic hypotension—Docetaxel—melanoma	0.000345	0.00193	CcSEcCtD
Propafenone—Rash—Vemurafenib—melanoma	0.000344	0.00192	CcSEcCtD
Propafenone—Mental disorder—Temozolomide—melanoma	0.000344	0.00192	CcSEcCtD
Propafenone—Dermatitis—Vemurafenib—melanoma	0.000344	0.00192	CcSEcCtD
Propafenone—Headache—Vemurafenib—melanoma	0.000342	0.00191	CcSEcCtD
Propafenone—Erythema—Temozolomide—melanoma	0.000342	0.00191	CcSEcCtD
Propafenone—Malnutrition—Temozolomide—melanoma	0.000342	0.00191	CcSEcCtD
Propafenone—Breast disorder—Docetaxel—melanoma	0.000341	0.00191	CcSEcCtD
Propafenone—Discomfort—Bleomycin—melanoma	0.000341	0.0019	CcSEcCtD
Propafenone—Malaise—Dactinomycin—melanoma	0.000341	0.0019	CcSEcCtD
Propafenone—Cramp muscle—Docetaxel—melanoma	0.00034	0.0019	CcSEcCtD
Propafenone—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00034	0.0019	CcSEcCtD
Propafenone—Leukopenia—Dactinomycin—melanoma	0.000339	0.00189	CcSEcCtD
Propafenone—Dysgeusia—Temozolomide—melanoma	0.000335	0.00187	CcSEcCtD
Propafenone—Confusional state—Bleomycin—melanoma	0.000334	0.00186	CcSEcCtD
Propafenone—Vision blurred—Carmustine—melanoma	0.000334	0.00186	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Docetaxel—melanoma	0.000333	0.00186	CcSEcCtD
Propafenone—Tremor—Carmustine—melanoma	0.000332	0.00185	CcSEcCtD
Propafenone—Oedema—Bleomycin—melanoma	0.000331	0.00185	CcSEcCtD
Propafenone—Infection—Bleomycin—melanoma	0.000329	0.00184	CcSEcCtD
Propafenone—Anaemia—Carmustine—melanoma	0.000327	0.00183	CcSEcCtD
Propafenone—Dysphagia—Docetaxel—melanoma	0.000326	0.00182	CcSEcCtD
Propafenone—Nausea—Vemurafenib—melanoma	0.000324	0.00181	CcSEcCtD
Propafenone—Thrombocytopenia—Bleomycin—melanoma	0.000324	0.00181	CcSEcCtD
Propafenone—Vision blurred—Temozolomide—melanoma	0.000322	0.0018	CcSEcCtD
Propafenone—Myalgia—Dactinomycin—melanoma	0.000322	0.0018	CcSEcCtD
Propafenone—Tremor—Temozolomide—melanoma	0.00032	0.00179	CcSEcCtD
Propafenone—Discomfort—Dactinomycin—melanoma	0.000318	0.00178	CcSEcCtD
Propafenone—Angina pectoris—Docetaxel—melanoma	0.000318	0.00178	CcSEcCtD
Propafenone—Ill-defined disorder—Temozolomide—melanoma	0.000317	0.00177	CcSEcCtD
Propafenone—Leukopenia—Carmustine—melanoma	0.000317	0.00177	CcSEcCtD
Propafenone—Anaemia—Temozolomide—melanoma	0.000316	0.00177	CcSEcCtD
Propafenone—Anorexia—Bleomycin—melanoma	0.000315	0.00176	CcSEcCtD
Propafenone—Hypotension—Bleomycin—melanoma	0.000309	0.00173	CcSEcCtD
Propafenone—Oedema—Dactinomycin—melanoma	0.000309	0.00172	CcSEcCtD
Propafenone—Malaise—Temozolomide—melanoma	0.000308	0.00172	CcSEcCtD
Propafenone—Vertigo—Temozolomide—melanoma	0.000307	0.00172	CcSEcCtD
Propafenone—Convulsion—Carmustine—melanoma	0.000307	0.00171	CcSEcCtD
Propafenone—Infection—Dactinomycin—melanoma	0.000307	0.00171	CcSEcCtD
Propafenone—Leukopenia—Temozolomide—melanoma	0.000306	0.00171	CcSEcCtD
Propafenone—Hypertension—Carmustine—melanoma	0.000306	0.00171	CcSEcCtD
Propafenone—Palpitations—Temozolomide—melanoma	0.000302	0.00169	CcSEcCtD
Propafenone—Thrombocytopenia—Dactinomycin—melanoma	0.000302	0.00169	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000302	0.00168	CcSEcCtD
Propafenone—Chest pain—Carmustine—melanoma	0.000301	0.00168	CcSEcCtD
Propafenone—Myalgia—Carmustine—melanoma	0.000301	0.00168	CcSEcCtD
Propafenone—Mirabegron—ALB—melanoma	0.000301	0.0348	CrCbGaD
Propafenone—Anxiety—Carmustine—melanoma	0.0003	0.00168	CcSEcCtD
Propafenone—Cough—Temozolomide—melanoma	0.000298	0.00167	CcSEcCtD
Propafenone—Paraesthesia—Bleomycin—melanoma	0.000297	0.00166	CcSEcCtD
Propafenone—Weight increased—Docetaxel—melanoma	0.000297	0.00166	CcSEcCtD
Propafenone—Convulsion—Temozolomide—melanoma	0.000296	0.00166	CcSEcCtD
Propafenone—Weight decreased—Docetaxel—melanoma	0.000295	0.00165	CcSEcCtD
Propafenone—Hypertension—Temozolomide—melanoma	0.000295	0.00165	CcSEcCtD
Propafenone—Dyspnoea—Bleomycin—melanoma	0.000295	0.00165	CcSEcCtD
Propafenone—Anorexia—Dactinomycin—melanoma	0.000294	0.00164	CcSEcCtD
Propafenone—Confusional state—Carmustine—melanoma	0.000291	0.00163	CcSEcCtD
Propafenone—Myalgia—Temozolomide—melanoma	0.000291	0.00163	CcSEcCtD
Propafenone—Infestation NOS—Docetaxel—melanoma	0.000291	0.00163	CcSEcCtD
Propafenone—Infestation—Docetaxel—melanoma	0.000291	0.00163	CcSEcCtD
Propafenone—Anxiety—Temozolomide—melanoma	0.00029	0.00162	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000289	0.00162	CcSEcCtD
Propafenone—Oedema—Carmustine—melanoma	0.000289	0.00161	CcSEcCtD
Propafenone—Discomfort—Temozolomide—melanoma	0.000288	0.00161	CcSEcCtD
Propafenone—Decreased appetite—Bleomycin—melanoma	0.000288	0.00161	CcSEcCtD
Propafenone—Mirabegron—ABCB1—melanoma	0.000287	0.0332	CrCbGaD
Propafenone—Infection—Carmustine—melanoma	0.000287	0.0016	CcSEcCtD
Propafenone—Renal failure—Docetaxel—melanoma	0.000286	0.0016	CcSEcCtD
Propafenone—Neuropathy peripheral—Docetaxel—melanoma	0.000285	0.00159	CcSEcCtD
Propafenone—Dry mouth—Temozolomide—melanoma	0.000285	0.00159	CcSEcCtD
Propafenone—Stomatitis—Docetaxel—melanoma	0.000284	0.00158	CcSEcCtD
Propafenone—Jaundice—Docetaxel—melanoma	0.000284	0.00158	CcSEcCtD
Propafenone—Pain—Bleomycin—melanoma	0.000283	0.00158	CcSEcCtD
Propafenone—Thrombocytopenia—Carmustine—melanoma	0.000283	0.00158	CcSEcCtD
Propafenone—Tachycardia—Carmustine—melanoma	0.000282	0.00157	CcSEcCtD
Propafenone—Confusional state—Temozolomide—melanoma	0.000281	0.00157	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000281	0.00157	CcSEcCtD
Propafenone—Oedema—Temozolomide—melanoma	0.000279	0.00156	CcSEcCtD
Propafenone—Infection—Temozolomide—melanoma	0.000277	0.00155	CcSEcCtD
Propafenone—Anorexia—Carmustine—melanoma	0.000275	0.00154	CcSEcCtD
Propafenone—Hepatobiliary disease—Docetaxel—melanoma	0.000275	0.00154	CcSEcCtD
Propafenone—Epistaxis—Docetaxel—melanoma	0.000275	0.00153	CcSEcCtD
Propafenone—Nervous system disorder—Temozolomide—melanoma	0.000274	0.00153	CcSEcCtD
Propafenone—Thrombocytopenia—Temozolomide—melanoma	0.000273	0.00153	CcSEcCtD
Propafenone—Feeling abnormal—Bleomycin—melanoma	0.000273	0.00152	CcSEcCtD
Propafenone—Agranulocytosis—Docetaxel—melanoma	0.000272	0.00152	CcSEcCtD
Propafenone—Skin disorder—Temozolomide—melanoma	0.000271	0.00151	CcSEcCtD
Propafenone—Hypotension—Carmustine—melanoma	0.00027	0.00151	CcSEcCtD
Propafenone—Hyperhidrosis—Temozolomide—melanoma	0.00027	0.00151	CcSEcCtD
Propafenone—Decreased appetite—Dactinomycin—melanoma	0.000268	0.0015	CcSEcCtD
Propafenone—Fatigue—Dactinomycin—melanoma	0.000266	0.00149	CcSEcCtD
Propafenone—Anorexia—Temozolomide—melanoma	0.000266	0.00149	CcSEcCtD
Propafenone—Pain—Dactinomycin—melanoma	0.000264	0.00147	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Carmustine—melanoma	0.000263	0.00147	CcSEcCtD
Propafenone—Urticaria—Bleomycin—melanoma	0.000263	0.00147	CcSEcCtD
Propafenone—Haemoglobin—Docetaxel—melanoma	0.000263	0.00147	CcSEcCtD
Propafenone—Rhinitis—Docetaxel—melanoma	0.000262	0.00146	CcSEcCtD
Propafenone—Body temperature increased—Bleomycin—melanoma	0.000262	0.00146	CcSEcCtD
Propafenone—Haemorrhage—Docetaxel—melanoma	0.000261	0.00146	CcSEcCtD
Propafenone—Hepatitis—Docetaxel—melanoma	0.000261	0.00146	CcSEcCtD
Propafenone—Insomnia—Carmustine—melanoma	0.000261	0.00146	CcSEcCtD
Propafenone—Hypoaesthesia—Docetaxel—melanoma	0.00026	0.00145	CcSEcCtD
Propafenone—Paraesthesia—Carmustine—melanoma	0.000259	0.00145	CcSEcCtD
Propafenone—Urinary tract disorder—Docetaxel—melanoma	0.000258	0.00144	CcSEcCtD
Propafenone—Dyspnoea—Carmustine—melanoma	0.000258	0.00144	CcSEcCtD
Propafenone—Somnolence—Carmustine—melanoma	0.000257	0.00143	CcSEcCtD
Propafenone—Connective tissue disorder—Docetaxel—melanoma	0.000257	0.00143	CcSEcCtD
Propafenone—Urethral disorder—Docetaxel—melanoma	0.000256	0.00143	CcSEcCtD
Propafenone—Feeling abnormal—Dactinomycin—melanoma	0.000254	0.00142	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000254	0.00142	CcSEcCtD
Propafenone—Insomnia—Temozolomide—melanoma	0.000252	0.00141	CcSEcCtD
Propafenone—Gastrointestinal pain—Dactinomycin—melanoma	0.000252	0.00141	CcSEcCtD
Propafenone—Visual impairment—Docetaxel—melanoma	0.000252	0.00141	CcSEcCtD
Propafenone—Decreased appetite—Carmustine—melanoma	0.000251	0.0014	CcSEcCtD
Propafenone—Paraesthesia—Temozolomide—melanoma	0.000251	0.0014	CcSEcCtD
Propafenone—Gastrointestinal disorder—Carmustine—melanoma	0.000249	0.00139	CcSEcCtD
Propafenone—Dyspnoea—Temozolomide—melanoma	0.000249	0.00139	CcSEcCtD
Propafenone—Somnolence—Temozolomide—melanoma	0.000248	0.00139	CcSEcCtD
Propafenone—Constipation—Carmustine—melanoma	0.000247	0.00138	CcSEcCtD
Propafenone—Pain—Carmustine—melanoma	0.000247	0.00138	CcSEcCtD
Propafenone—Dyspepsia—Temozolomide—melanoma	0.000246	0.00137	CcSEcCtD
Propafenone—Eye disorder—Docetaxel—melanoma	0.000244	0.00136	CcSEcCtD
Propafenone—Oxaprozin—PTGS2—melanoma	0.000244	0.0282	CrCbGaD
Propafenone—Salsalate—PTGS2—melanoma	0.000244	0.0282	CrCbGaD
Propafenone—Abdominal pain—Dactinomycin—melanoma	0.000244	0.00136	CcSEcCtD
Propafenone—Body temperature increased—Dactinomycin—melanoma	0.000244	0.00136	CcSEcCtD
Propafenone—Hypersensitivity—Bleomycin—melanoma	0.000244	0.00136	CcSEcCtD
Propafenone—Decreased appetite—Temozolomide—melanoma	0.000243	0.00136	CcSEcCtD
Propafenone—Flushing—Docetaxel—melanoma	0.000243	0.00135	CcSEcCtD
Propafenone—Cardiac disorder—Docetaxel—melanoma	0.000243	0.00135	CcSEcCtD
Propafenone—Gastrointestinal disorder—Temozolomide—melanoma	0.000241	0.00135	CcSEcCtD
Propafenone—Fatigue—Temozolomide—melanoma	0.000241	0.00134	CcSEcCtD
Propafenone—Pain—Temozolomide—melanoma	0.000239	0.00133	CcSEcCtD
Propafenone—Constipation—Temozolomide—melanoma	0.000239	0.00133	CcSEcCtD
Propafenone—Feeling abnormal—Carmustine—melanoma	0.000238	0.00133	CcSEcCtD
Propafenone—Asthenia—Bleomycin—melanoma	0.000237	0.00133	CcSEcCtD
Propafenone—Angiopathy—Docetaxel—melanoma	0.000237	0.00132	CcSEcCtD
Propafenone—Gastrointestinal pain—Carmustine—melanoma	0.000236	0.00132	CcSEcCtD
Propafenone—Immune system disorder—Docetaxel—melanoma	0.000236	0.00132	CcSEcCtD
Propafenone—Mediastinal disorder—Docetaxel—melanoma	0.000235	0.00132	CcSEcCtD
Propafenone—Pruritus—Bleomycin—melanoma	0.000234	0.00131	CcSEcCtD
Propafenone—Arrhythmia—Docetaxel—melanoma	0.000233	0.0013	CcSEcCtD
Propafenone—Alopecia—Docetaxel—melanoma	0.000231	0.00129	CcSEcCtD
Propafenone—Feeling abnormal—Temozolomide—melanoma	0.00023	0.00128	CcSEcCtD
Propafenone—Mental disorder—Docetaxel—melanoma	0.000229	0.00128	CcSEcCtD
Propafenone—Abdominal pain—Carmustine—melanoma	0.000228	0.00128	CcSEcCtD
Propafenone—Body temperature increased—Carmustine—melanoma	0.000228	0.00128	CcSEcCtD
Propafenone—Gastrointestinal pain—Temozolomide—melanoma	0.000228	0.00127	CcSEcCtD
Propafenone—Erythema—Docetaxel—melanoma	0.000227	0.00127	CcSEcCtD
Propafenone—Malnutrition—Docetaxel—melanoma	0.000227	0.00127	CcSEcCtD
Propafenone—Hypersensitivity—Dactinomycin—melanoma	0.000227	0.00127	CcSEcCtD
Propafenone—Dysgeusia—Docetaxel—melanoma	0.000223	0.00124	CcSEcCtD
Propafenone—Urticaria—Temozolomide—melanoma	0.000222	0.00124	CcSEcCtD
Propafenone—Asthenia—Dactinomycin—melanoma	0.000221	0.00124	CcSEcCtD
Propafenone—Abdominal pain—Temozolomide—melanoma	0.000221	0.00123	CcSEcCtD
Propafenone—Body temperature increased—Temozolomide—melanoma	0.000221	0.00123	CcSEcCtD
Propafenone—Muscle spasms—Docetaxel—melanoma	0.000219	0.00122	CcSEcCtD
Propafenone—Hypersensitivity—Carmustine—melanoma	0.000213	0.00119	CcSEcCtD
Propafenone—Diarrhoea—Dactinomycin—melanoma	0.000211	0.00118	CcSEcCtD
Propafenone—Vomiting—Bleomycin—melanoma	0.00021	0.00118	CcSEcCtD
Propafenone—Anaemia—Docetaxel—melanoma	0.00021	0.00117	CcSEcCtD
Propafenone—Rash—Bleomycin—melanoma	0.000209	0.00117	CcSEcCtD
Propafenone—Dermatitis—Bleomycin—melanoma	0.000208	0.00116	CcSEcCtD
Propafenone—Asthenia—Carmustine—melanoma	0.000207	0.00116	CcSEcCtD
Propafenone—Hypersensitivity—Temozolomide—melanoma	0.000206	0.00115	CcSEcCtD
Propafenone—Syncope—Docetaxel—melanoma	0.000204	0.00114	CcSEcCtD
Propafenone—Leukopenia—Docetaxel—melanoma	0.000204	0.00114	CcSEcCtD
Propafenone—Palpitations—Docetaxel—melanoma	0.000201	0.00112	CcSEcCtD
Propafenone—Asthenia—Temozolomide—melanoma	0.0002	0.00112	CcSEcCtD
Propafenone—Loss of consciousness—Docetaxel—melanoma	0.0002	0.00112	CcSEcCtD
Propafenone—Cough—Docetaxel—melanoma	0.000198	0.00111	CcSEcCtD
Propafenone—Diarrhoea—Carmustine—melanoma	0.000198	0.0011	CcSEcCtD
Propafenone—Pruritus—Temozolomide—melanoma	0.000197	0.0011	CcSEcCtD
Propafenone—Convulsion—Docetaxel—melanoma	0.000197	0.0011	CcSEcCtD
Propafenone—Nausea—Bleomycin—melanoma	0.000197	0.0011	CcSEcCtD
Propafenone—Hypertension—Docetaxel—melanoma	0.000196	0.0011	CcSEcCtD
Propafenone—Vomiting—Dactinomycin—melanoma	0.000196	0.0011	CcSEcCtD
Propafenone—Rash—Dactinomycin—melanoma	0.000195	0.00109	CcSEcCtD
Propafenone—Chest pain—Docetaxel—melanoma	0.000194	0.00108	CcSEcCtD
Propafenone—Myalgia—Docetaxel—melanoma	0.000194	0.00108	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000192	0.00107	CcSEcCtD
Propafenone—Dizziness—Carmustine—melanoma	0.000191	0.00107	CcSEcCtD
Propafenone—Diarrhoea—Temozolomide—melanoma	0.000191	0.00107	CcSEcCtD
Propafenone—Dry mouth—Docetaxel—melanoma	0.000189	0.00106	CcSEcCtD
Propafenone—Confusional state—Docetaxel—melanoma	0.000187	0.00105	CcSEcCtD
Propafenone—Oedema—Docetaxel—melanoma	0.000186	0.00104	CcSEcCtD
Propafenone—Dizziness—Temozolomide—melanoma	0.000185	0.00103	CcSEcCtD
Propafenone—Infection—Docetaxel—melanoma	0.000184	0.00103	CcSEcCtD
Propafenone—Vomiting—Carmustine—melanoma	0.000184	0.00103	CcSEcCtD
Propafenone—Nausea—Dactinomycin—melanoma	0.000183	0.00102	CcSEcCtD
Propafenone—Shock—Docetaxel—melanoma	0.000183	0.00102	CcSEcCtD
Propafenone—Rash—Carmustine—melanoma	0.000182	0.00102	CcSEcCtD
Propafenone—Nervous system disorder—Docetaxel—melanoma	0.000182	0.00102	CcSEcCtD
Propafenone—Dermatitis—Carmustine—melanoma	0.000182	0.00102	CcSEcCtD
Propafenone—Thrombocytopenia—Docetaxel—melanoma	0.000182	0.00102	CcSEcCtD
Propafenone—Tachycardia—Docetaxel—melanoma	0.000181	0.00101	CcSEcCtD
Propafenone—Headache—Carmustine—melanoma	0.000181	0.00101	CcSEcCtD
Propafenone—Skin disorder—Docetaxel—melanoma	0.00018	0.00101	CcSEcCtD
Propafenone—Vomiting—Temozolomide—melanoma	0.000177	0.000991	CcSEcCtD
Propafenone—Anorexia—Docetaxel—melanoma	0.000177	0.000988	CcSEcCtD
Propafenone—Rash—Temozolomide—melanoma	0.000176	0.000983	CcSEcCtD
Propafenone—Dermatitis—Temozolomide—melanoma	0.000176	0.000982	CcSEcCtD
Propafenone—Headache—Temozolomide—melanoma	0.000175	0.000977	CcSEcCtD
Propafenone—Hypotension—Docetaxel—melanoma	0.000173	0.000969	CcSEcCtD
Propafenone—Nausea—Carmustine—melanoma	0.000172	0.000958	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000169	0.000945	CcSEcCtD
Propafenone—Insomnia—Docetaxel—melanoma	0.000168	0.000938	CcSEcCtD
Propafenone—Paraesthesia—Docetaxel—melanoma	0.000167	0.000931	CcSEcCtD
Propafenone—Nausea—Temozolomide—melanoma	0.000166	0.000926	CcSEcCtD
Propafenone—Dyspnoea—Docetaxel—melanoma	0.000166	0.000924	CcSEcCtD
Propafenone—Somnolence—Docetaxel—melanoma	0.000165	0.000922	CcSEcCtD
Propafenone—Dyspepsia—Docetaxel—melanoma	0.000163	0.000913	CcSEcCtD
Propafenone—Decreased appetite—Docetaxel—melanoma	0.000161	0.000901	CcSEcCtD
Propafenone—Gastrointestinal disorder—Docetaxel—melanoma	0.00016	0.000895	CcSEcCtD
Propafenone—Fatigue—Docetaxel—melanoma	0.00016	0.000894	CcSEcCtD
Propafenone—Pain—Docetaxel—melanoma	0.000159	0.000887	CcSEcCtD
Propafenone—Constipation—Docetaxel—melanoma	0.000159	0.000887	CcSEcCtD
Propafenone—Feeling abnormal—Docetaxel—melanoma	0.000153	0.000854	CcSEcCtD
Propafenone—Gastrointestinal pain—Docetaxel—melanoma	0.000152	0.000848	CcSEcCtD
Propafenone—Body temperature increased—Docetaxel—melanoma	0.000147	0.00082	CcSEcCtD
Propafenone—Abdominal pain—Docetaxel—melanoma	0.000147	0.00082	CcSEcCtD
Propafenone—Hypersensitivity—Docetaxel—melanoma	0.000137	0.000764	CcSEcCtD
Propafenone—Asthenia—Docetaxel—melanoma	0.000133	0.000744	CcSEcCtD
Propafenone—Pruritus—Docetaxel—melanoma	0.000131	0.000734	CcSEcCtD
Propafenone—Diarrhoea—Docetaxel—melanoma	0.000127	0.000709	CcSEcCtD
Propafenone—Dizziness—Docetaxel—melanoma	0.000123	0.000686	CcSEcCtD
Propafenone—Vomiting—Docetaxel—melanoma	0.000118	0.000659	CcSEcCtD
Propafenone—Rash—Docetaxel—melanoma	0.000117	0.000654	CcSEcCtD
Propafenone—Dermatitis—Docetaxel—melanoma	0.000117	0.000653	CcSEcCtD
Propafenone—Headache—Docetaxel—melanoma	0.000116	0.00065	CcSEcCtD
Propafenone—Carvedilol—ABCB1—melanoma	0.000115	0.0133	CrCbGaD
Propafenone—Nausea—Docetaxel—melanoma	0.00011	0.000616	CcSEcCtD
Propafenone—Fentanyl—ABCB1—melanoma	0.000105	0.0121	CrCbGaD
Propafenone—Propranolol—ABCB1—melanoma	8.78e-05	0.0101	CrCbGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CG—melanoma	1.51e-05	0.000216	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HPSE—melanoma	1.5e-05	0.000214	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SYK—melanoma	1.48e-05	0.000211	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CUBN—melanoma	1.47e-05	0.00021	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PLA2G6—melanoma	1.47e-05	0.00021	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	1.46e-05	0.000209	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NGFR—melanoma	1.45e-05	0.000207	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT3—melanoma	1.45e-05	0.000207	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ITGAV—melanoma	1.45e-05	0.000207	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLCB4—melanoma	1.45e-05	0.000207	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.43e-05	0.000205	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SDHD—melanoma	1.42e-05	0.000203	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—BSG—melanoma	1.42e-05	0.000203	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CSPG4—melanoma	1.42e-05	0.000203	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.4e-05	0.000199	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PLA2G6—melanoma	1.38e-05	0.000197	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.38e-05	0.000197	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPAM—melanoma	1.38e-05	0.000197	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PLA2G6—melanoma	1.37e-05	0.000196	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC6A11—melanoma	1.36e-05	0.000194	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIP4K2A—melanoma	1.36e-05	0.000194	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.35e-05	0.000193	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SOCS1—melanoma	1.34e-05	0.000192	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAP2K1—melanoma	1.34e-05	0.000191	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—S100B—melanoma	1.34e-05	0.000191	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CD—melanoma	1.33e-05	0.00019	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTAP—melanoma	1.33e-05	0.000189	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—VCAN—melanoma	1.32e-05	0.000188	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ERBB4—melanoma	1.28e-05	0.000183	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	1.28e-05	0.000182	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP17A1—melanoma	1.28e-05	0.000182	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN2B—melanoma	1.27e-05	0.000181	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.26e-05	0.00018	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.24e-05	0.000177	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—VCAN—melanoma	1.24e-05	0.000177	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—VCAN—melanoma	1.23e-05	0.000176	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CD86—melanoma	1.23e-05	0.000175	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCL8—melanoma	1.23e-05	0.000175	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EDN1—melanoma	1.22e-05	0.000174	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GNA11—melanoma	1.21e-05	0.000172	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CSF2—melanoma	1.19e-05	0.00017	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGF1—melanoma	1.19e-05	0.00017	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PHGDH—melanoma	1.18e-05	0.000169	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LUM—melanoma	1.18e-05	0.000169	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—FASN—melanoma	1.18e-05	0.000168	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—IL2—melanoma	1.17e-05	0.000167	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PLA2G6—melanoma	1.17e-05	0.000167	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.17e-05	0.000166	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—E2F1—melanoma	1.16e-05	0.000166	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SLC5A5—melanoma	1.16e-05	0.000166	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CB—melanoma	1.16e-05	0.000166	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HPSE—melanoma	1.16e-05	0.000165	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PDGFRA—melanoma	1.15e-05	0.000165	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PRKCA—melanoma	1.14e-05	0.000163	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ITGB3—melanoma	1.14e-05	0.000163	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.14e-05	0.000163	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CUBN—melanoma	1.14e-05	0.000162	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.13e-05	0.000161	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GNAQ—melanoma	1.12e-05	0.00016	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CD44—melanoma	1.12e-05	0.00016	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SPP1—melanoma	1.12e-05	0.00016	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAP2K2—melanoma	1.12e-05	0.000159	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCL8—melanoma	1.11e-05	0.000159	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP17A1—melanoma	1.11e-05	0.000159	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SDHD—melanoma	1.1e-05	0.000157	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CSPG4—melanoma	1.1e-05	0.000157	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—BSG—melanoma	1.1e-05	0.000157	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.1e-05	0.000157	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.09e-05	0.000155	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1B1—melanoma	1.07e-05	0.000153	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2—melanoma	1.06e-05	0.000152	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPAM—melanoma	1.06e-05	0.000152	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TERT—melanoma	1.06e-05	0.000151	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RAC1—melanoma	1.06e-05	0.000151	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—VCAN—melanoma	1.05e-05	0.00015	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GNA11—melanoma	1.05e-05	0.00015	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP17A1—melanoma	1.05e-05	0.00015	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP17A1—melanoma	1.04e-05	0.000148	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.03e-05	0.000147	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—FASN—melanoma	1.03e-05	0.000147	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.02e-05	0.000146	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HIF1A—melanoma	1.01e-05	0.000145	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.01e-05	0.000144	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SLC5A5—melanoma	1.01e-05	0.000144	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.96e-06	0.000142	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GNA11—melanoma	9.9e-06	0.000141	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GNA11—melanoma	9.81e-06	0.00014	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GNAQ—melanoma	9.77e-06	0.000139	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CD44—melanoma	9.77e-06	0.000139	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KDR—melanoma	9.7e-06	0.000139	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—FASN—melanoma	9.69e-06	0.000138	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.62e-06	0.000137	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—FASN—melanoma	9.6e-06	0.000137	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SLC5A5—melanoma	9.53e-06	0.000136	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.48e-06	0.000135	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SLC5A5—melanoma	9.45e-06	0.000135	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1B1—melanoma	9.36e-06	0.000134	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FN1—melanoma	9.34e-06	0.000133	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GNAQ—melanoma	9.2e-06	0.000131	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CD44—melanoma	9.2e-06	0.000131	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH1—melanoma	9.14e-06	0.000131	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CD44—melanoma	9.12e-06	0.00013	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GNAQ—melanoma	9.12e-06	0.00013	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLA2G6—melanoma	9.04e-06	0.000129	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CD80—melanoma	8.96e-06	0.000128	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CG—melanoma	8.94e-06	0.000128	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APC—melanoma	8.94e-06	0.000128	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KIT—melanoma	8.94e-06	0.000128	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—NRAS—melanoma	8.94e-06	0.000128	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.93e-06	0.000128	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP17A1—melanoma	8.88e-06	0.000127	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.85e-06	0.000126	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ABCB1—melanoma	8.85e-06	0.000126	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGF—melanoma	8.84e-06	0.000126	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1B1—melanoma	8.82e-06	0.000126	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.76e-06	0.000125	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1B1—melanoma	8.75e-06	0.000125	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	8.65e-06	0.000123	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK3—melanoma	8.56e-06	0.000122	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—BRAF—melanoma	8.4e-06	0.00012	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GNA11—melanoma	8.39e-06	0.00012	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—FASN—melanoma	8.21e-06	0.000117	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1—melanoma	8.19e-06	0.000117	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK1—melanoma	8.15e-06	0.000116	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PRKCA—melanoma	8.14e-06	0.000116	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—melanoma	8.14e-06	0.000116	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—VCAN—melanoma	8.12e-06	0.000116	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ERCC2—melanoma	8.08e-06	0.000115	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC5A5—melanoma	8.07e-06	0.000115	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAP2K1—melanoma	7.91e-06	0.000113	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CD—melanoma	7.86e-06	0.000112	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CD44—melanoma	7.8e-06	0.000111	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GNAQ—melanoma	7.8e-06	0.000111	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	7.78e-06	0.000111	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.72e-06	0.00011	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—KRAS—melanoma	7.69e-06	0.00011	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.63e-06	0.000109	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.56e-06	0.000108	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGF2—melanoma	7.52e-06	0.000107	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1B1—melanoma	7.47e-06	0.000107	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCB1—melanoma	7.27e-06	0.000104	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCB1—melanoma	7.2e-06	0.000103	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PRKCA—melanoma	7.1e-06	0.000101	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CA—melanoma	7.07e-06	0.000101	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MDM2—melanoma	7.04e-06	0.000101	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ERCC2—melanoma	7.04e-06	0.0001	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ERBB2—melanoma	6.94e-06	9.91e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP17A1—melanoma	6.85e-06	9.78e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CB—melanoma	6.85e-06	9.78e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.69e-06	9.55e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PRKCA—melanoma	6.69e-06	9.55e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ERCC2—melanoma	6.63e-06	9.47e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PRKCA—melanoma	6.63e-06	9.46e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.6e-06	9.42e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL8—melanoma	6.58e-06	9.4e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ERCC2—melanoma	6.57e-06	9.39e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HRAS—melanoma	6.54e-06	9.34e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GNA11—melanoma	6.47e-06	9.24e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1B—melanoma	6.43e-06	9.18e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CG—melanoma	6.38e-06	9.11e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—melanoma	6.36e-06	9.08e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—FASN—melanoma	6.33e-06	9.04e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CASP3—melanoma	6.3e-06	8.99e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—melanoma	6.29e-06	8.98e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—melanoma	6.26e-06	8.94e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC5A5—melanoma	6.23e-06	8.89e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARG—melanoma	6.16e-06	8.79e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCB1—melanoma	6.16e-06	8.79e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—melanoma	6.13e-06	8.76e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CTNNB1—melanoma	6.07e-06	8.67e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GNAQ—melanoma	6.02e-06	8.59e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CD44—melanoma	6.02e-06	8.59e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—melanoma	5.95e-06	8.5e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1A—melanoma	5.93e-06	8.47e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTEN—melanoma	5.92e-06	8.45e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NFKB1—melanoma	5.89e-06	8.41e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—melanoma	5.77e-06	8.24e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1B1—melanoma	5.77e-06	8.24e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PRKCA—melanoma	5.66e-06	8.09e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ERCC2—melanoma	5.62e-06	8.02e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CD—melanoma	5.61e-06	8.01e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CG—melanoma	5.56e-06	7.93e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—melanoma	5.54e-06	7.9e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.45e-06	7.77e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARG—melanoma	5.36e-06	7.66e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—melanoma	5.35e-06	7.63e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT3—melanoma	5.29e-06	7.56e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NRAS—melanoma	5.28e-06	7.54e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CG—melanoma	5.24e-06	7.48e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CG—melanoma	5.19e-06	7.41e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK3—melanoma	5.06e-06	7.22e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARG—melanoma	5.05e-06	7.22e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARG—melanoma	5.01e-06	7.15e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—melanoma	4.92e-06	7.02e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CB—melanoma	4.89e-06	6.98e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CD—melanoma	4.89e-06	6.98e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—melanoma	4.84e-06	6.92e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—melanoma	4.82e-06	6.89e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK1—melanoma	4.81e-06	6.87e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—melanoma	4.81e-06	6.87e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCB1—melanoma	4.75e-06	6.78e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.65e-06	6.64e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CD—melanoma	4.6e-06	6.57e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CD—melanoma	4.56e-06	6.52e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KRAS—melanoma	4.55e-06	6.49e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—melanoma	4.55e-06	6.49e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—melanoma	4.51e-06	6.43e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CG—melanoma	4.44e-06	6.33e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PRKCA—melanoma	4.37e-06	6.24e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ERCC2—melanoma	4.34e-06	6.19e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARG—melanoma	4.28e-06	6.11e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CB—melanoma	4.26e-06	6.08e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTEN—melanoma	4.22e-06	6.03e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—melanoma	4.22e-06	6.02e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CA—melanoma	4.18e-06	5.96e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—melanoma	4.04e-06	5.77e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CB—melanoma	4.01e-06	5.73e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CB—melanoma	3.98e-06	5.68e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—melanoma	3.98e-06	5.68e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—melanoma	3.94e-06	5.63e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CD—melanoma	3.9e-06	5.57e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HRAS—melanoma	3.86e-06	5.52e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—melanoma	3.85e-06	5.5e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—melanoma	3.7e-06	5.28e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTEN—melanoma	3.68e-06	5.25e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTEN—melanoma	3.47e-06	4.95e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTEN—melanoma	3.44e-06	4.91e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CG—melanoma	3.42e-06	4.89e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—melanoma	3.41e-06	4.87e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CB—melanoma	3.4e-06	4.85e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—melanoma	3.37e-06	4.81e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARG—melanoma	3.3e-06	4.72e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CD—melanoma	3.01e-06	4.3e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CA—melanoma	2.98e-06	4.25e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—melanoma	2.97e-06	4.24e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTEN—melanoma	2.94e-06	4.19e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CB—melanoma	2.62e-06	3.75e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—melanoma	2.6e-06	3.71e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CA—melanoma	2.6e-06	3.71e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CA—melanoma	2.45e-06	3.49e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—melanoma	2.43e-06	3.48e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CA—melanoma	2.43e-06	3.46e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTEN—melanoma	2.27e-06	3.24e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—melanoma	2.12e-06	3.03e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CA—melanoma	2.07e-06	2.96e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—melanoma	2e-06	2.85e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—melanoma	1.98e-06	2.83e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—melanoma	1.69e-06	2.42e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CA—melanoma	1.6e-06	2.28e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—melanoma	1.31e-06	1.87e-05	CbGpPWpGaD
